HORGAN KEVIN 4
4 · Seres Therapeutics, Inc. · Filed Oct 24, 2018
Insider Transaction Report
Form 4
HORGAN KEVIN
Chief Medical Officer and EVP
Transactions
- Award
Stock Option (right to buy)
2018-10-23+225,000→ 225,000 totalExercise: $6.58Exp: 2028-10-22→ Common Stock (225,000 underlying)
Footnotes (1)
- [F1]The Option will vest as to 25% of the shares on October 22, 2019. The remainder of the shares will vest in 12 equal quarterly installments thereafter